Copenhagen-based Biograil raises €20 million in a funding round for its innovative oral drug delivery device, with support from Verve Ventures and Megatrend Invest.
Amount Raised
€20 Million
Round Type
Venture
CopenhagenBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Biograil, a BioTech company in Copenhagen, has secured €20 million in a funding round to further develop its oral drug delivery device. The round was supported by investors including Verve Ventures and Megatrend Invest, with participation from HTGF. This funding will assist Biograil in advancing its proprietary BIONDD technology towards clinical development. The device aims to provide an alternative to injections for delivering therapeutics.
Quick answer
Biograil raised €20 Million in a funding round, dated November 4, 2026. Investors: Htgf, Megatrend Invest and Verve Ventures. Biograil is based in Copenhagen, Capital Region Of Denmark, Denmark.
- How much did Biograil raise?
- Biograil raised €20 Million in a funding round on November 4, 2026.
- Who invested in Biograil?
- Htgf, Megatrend Invest and Verve Ventures are named as investors in this round.
- What does Biograil do?
- Biograil is a Copenhagen-based BioTech company founded in 2019, focused on developing an oral device for delivering therapeutics that would otherwise require injection.
- Where is Biograil based and how big is it?
- Biograil is based in Copenhagen, Capital Region Of Denmark, Denmark. Fundz records about 31 employees.
- Who are the decision-makers at Biograil?
- Fundz holds 2 contacts at Biograil, including the Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Biograil that raised within 45 days of this round, from Fundz verified event records.
- Neurosterix raised $105M (Series B) on November 11, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Trior raised $25M (Series C) on October 23, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
Who to call at Biograil, and when
A new round usually means Biograil is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biograil raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biograil, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biograil. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biograil raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biograil raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.